Skip to main content

'KMED' Could Gain from Approval of Chinese Vaccine

By: ETFdb
On Tuesday, the World Health Organization approved a Covid-19 vaccine produced by Sinovac Biotech for emergency use, the second vaccine created in China to be approved according to Reuters .
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.